Mirabella Financial Services’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,121
Closed -$289K 894
2026
Q1
$289K Buy
+5,121
New +$334K 0.03% 519
2023
Q2
Sell
-18,324
Closed -$14M 556
2023
Q1
$14M Sell
18,324
-12,916
-41% -$1.05M 2.12% 5
2022
Q4
$2.46M Sell
31,240
-150,009
-83% -$12.1M 0.22% 76
2022
Q3
$13.4M Buy
181,249
+158,259
+688% +$11.4M 1.39% 10
2022
Q2
$1.5M Buy
+22,990
New +$1.36M 0.15% 140

Other funds holding HAE

Mirabella Financial Services's HAE Position: Q2 2026 in Review

Mirabella Financial Services sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 5,121 shares — an estimated $289K sold.

Mirabella Financial Services first reported a position in HAE in Q2 2022 and held it in 5 quarters. The position peaked at $14M in Q1 2023. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Mirabella Financial Services reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 5,121 Haemonetics shares in Q2 2026, an estimated $289K.
  • Mirabella Financial Services first reported a position in Haemonetics in Q2 2022 and held it in 5 quarters.
  • Mirabella Financial Services's Haemonetics position peaked at $14M in Q1 2023.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.